Company intelligence / Profile preview

Pulsalys

Villeurbanne, Auvergne-Rhône-Alpes, Francepulsalys.fr ↗

Ownership: Private
Development stage: Other

Overview

Pulsalys does not have its own clinical results but has enabled the transfer and development of multiple high-potential research projects from academic labs to industry. For example, it licensed a monoclonal antibody program targeting CK8 for cancer to iDD Biotech after successful preclinical proof-of-concept studies.

Industry: Investors

Partnerships

iDD BiotechCentre Léon Bérard Cancer Center/Lyon Cancer Research Center

Beyond the preview

Go deeper on Pulsalys.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pulsalys.

Explore the full profile